Early nutrition in preterm infants is essential for growth and neurodevelopment. The last decades more aggressive nutrition has been implemented in clinical practice to ensure optimal growth and thereby optimal neurodevelopmental outcome, as…
ID
Bron
Verkorte titel
Aandoening
preterm infants
body composition
neurodevelopmental outcome
nutrition
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
Body composition (percentage body fat) at 2 years corrected age
Neurodevelopmental outcome assessed by Bayley Scales of Infant and Toddler Development (mental and motor outcome measures) and eye-tracker at 2-years corrected age
Achtergrond van het onderzoek
This is a single-center ongoing, longitudinal observational cohort study conducted in the Netherlands. The aim of the study is to assess the association between body composition, as proxy of metabolic health, and neurodevelopmental outcome in preterm infants born before 30 weeks of gestation. Preterm infants are followed-up until the corrected age of 2 years with regular visits including body composition measurements, other markers of metabolic health and assessment of brain growth and neurodevelopmental outcome
Doel van het onderzoek
Early nutrition in preterm infants is essential for growth and neurodevelopment. The last decades more aggressive nutrition has been implemented in clinical practice to ensure optimal growth and thereby optimal neurodevelopmental outcome, as previous cohort studies showed that catch-up growth is associated with an improved neurodevelopmental outcome. However, it has also been shown recently that catch-up growth is associated with obesity and non-communicable diseases already in childhood. No studies assessed the influence of early growth and early nutrition on body composition in preterm infants in relation to neurodevelopmental outcome. We hypothesize that catch-up growth in the early postnatal period results in increased neonatal and childhood fat mass, but not in improved neurodevelopmental outcome.
Onderzoeksopzet
Follow-up at: term-equivalent age, 6 weeks, 6 months, 1 year and 2 years corrected age
Onderzoeksproduct en/of interventie
not applicable - observational trial
Publiek
Jorine A. Roelants
Rotterdam 3015 CN
The Netherlands
+31 10 7036015
j.roelants@erasmusmc.nl
Wetenschappelijk
Jorine A. Roelants
Rotterdam 3015 CN
The Netherlands
+31 10 7036015
j.roelants@erasmusmc.nl
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
Preterm birth < 30 weeks of gestation
Admission to NICU within 48 hours after birth
Written informed consent
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
Severe brain injury (IVH gr III/IV, post-hemorrhagic ventricular dilatation)
Perinatal asphyxia (pH < 7.00 and 5' min APGAR score <5)
Congenital TORCHES infection
Chromosomal abnormalities
Severe congenital anomalies
Opzet
Deelname
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL5831 |
NTR-old | NTR5985 |
Ander register | : MEC-2014-379 |